Prasarn Manitpisitkul

598 total citations
23 papers, 434 citations indexed

About

Prasarn Manitpisitkul is a scholar working on Pediatrics, Perinatology and Child Health, Sensory Systems and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Prasarn Manitpisitkul has authored 23 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pediatrics, Perinatology and Child Health, 6 papers in Sensory Systems and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Prasarn Manitpisitkul's work include Ion Channels and Receptors (6 papers), Epilepsy research and treatment (5 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Prasarn Manitpisitkul is often cited by papers focused on Ion Channels and Receptors (6 papers), Epilepsy research and treatment (5 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Prasarn Manitpisitkul collaborates with scholars based in United States, Belgium and India. Prasarn Manitpisitkul's co-authors include Ronald E. White, Kevin Shalayda, Win L. Chiou, John A. Moyer, Gary Romano, Arthur J. Mayorga, Lisa Ford, Christopher M. Flores, Shean‐Sheng Wang and Christopher R. Curtin and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmaceutical Sciences and Epilepsia.

In The Last Decade

Prasarn Manitpisitkul

23 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prasarn Manitpisitkul United States 15 86 82 81 78 78 23 434
Martijn L. Manson Sweden 10 210 2.4× 87 1.1× 111 1.4× 69 0.9× 44 0.6× 18 659
Yoshihiko Hirotani Japan 12 38 0.4× 34 0.4× 120 1.5× 28 0.4× 39 0.5× 53 522
Johan Wemer Netherlands 15 85 1.0× 11 0.1× 103 1.3× 59 0.8× 44 0.6× 34 460
Masataka Tajima Japan 13 58 0.7× 11 0.1× 87 1.1× 104 1.3× 51 0.7× 30 494
Megha Nagle United States 9 39 0.5× 26 0.3× 223 2.8× 66 0.8× 211 2.7× 9 742
V. A. John Switzerland 17 87 1.0× 9 0.1× 89 1.1× 158 2.0× 76 1.0× 34 716
Adrian Pereira United Kingdom 9 179 2.1× 16 0.2× 31 0.4× 42 0.5× 42 0.5× 14 402
Julie A. Johnson United States 9 29 0.3× 13 0.2× 60 0.7× 28 0.4× 38 0.5× 9 305
Nihayet Bayraktar Türkiye 11 46 0.5× 34 0.4× 108 1.3× 13 0.2× 19 0.2× 31 429
Takeshi Akiyoshi Japan 12 14 0.2× 42 0.5× 123 1.5× 45 0.6× 36 0.5× 50 461

Countries citing papers authored by Prasarn Manitpisitkul

Since Specialization
Citations

This map shows the geographic impact of Prasarn Manitpisitkul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prasarn Manitpisitkul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prasarn Manitpisitkul more than expected).

Fields of papers citing papers by Prasarn Manitpisitkul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prasarn Manitpisitkul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prasarn Manitpisitkul. The network helps show where Prasarn Manitpisitkul may publish in the future.

Co-authorship network of co-authors of Prasarn Manitpisitkul

This figure shows the co-authorship network connecting the top 25 collaborators of Prasarn Manitpisitkul. A scholar is included among the top collaborators of Prasarn Manitpisitkul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prasarn Manitpisitkul. Prasarn Manitpisitkul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manitpisitkul, Prasarn, Christopher M. Flores, John A. Moyer, et al.. (2018). A multiple-dose double-blind randomized study to evaluate the safety, pharmacokinetics, pharmacodynamics and analgesic efficacy of the TRPV1 antagonist JNJ-39439335 (mavatrep). Scandinavian Journal of Pain. 18(2). 151–164. 32 indexed citations
2.
Mayorga, Arthur J., Christopher M. Flores, Jeremiah Trudeau, et al.. (2017). A randomized study to evaluate the analgesic efficacy of a single dose of the TRPV1 antagonist mavatrep in patients with osteoarthritis. Scandinavian Journal of Pain. 17(1). 134–143. 34 indexed citations
3.
4.
Manitpisitkul, Prasarn, Kevin Shalayda, Panna Sanga, et al.. (2017). Pharmacokinetics and Safety of Mavatrep (JNJ‐39439335), a TRPV1 Antagonist in Healthy Japanese and Caucasian Men: A Double‐Blind, Randomized, Placebo‐Controlled, Sequential‐Group Phase 1 Study. Clinical Pharmacology in Drug Development. 7(7). 712–726. 5 indexed citations
5.
Manitpisitkul, Prasarn, Michael R. Brandt, Christopher M. Flores, et al.. (2016). TRPV1 antagonist JNJ-39439335 (mavatrep) demonstrates proof of pharmacology in healthy men: a first-in-human, double-blind, placebo-controlled, randomized, sequential group study. PAIN Reports. 1(4). e576–e576. 25 indexed citations
6.
Manitpisitkul, Prasarn, Arthur J. Mayorga, Kevin Shalayda, et al.. (2015). Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Learnings from a Double-Blind, Randomized, Placebo-Controlled, Sequential Group First-in-Human Study of the TRPV1 Antagonist, JNJ-38893777, in Healthy Men. Clinical Drug Investigation. 35(6). 353–363. 16 indexed citations
7.
Devineni, Damayanthi, Prasarn Manitpisitkul, Joseph Murphy, et al.. (2014). Effect of canagliflozin on the pharmacokinetics of glyburide, metformin, and simvastatin in healthy participants. Clinical Pharmacology in Drug Development. 4(3). 226–236. 18 indexed citations
8.
Devineni, Damayanthi, Prasarn Manitpisitkul, Joseph Murphy, et al.. (2014). Effect of food on the pharmacokinetics of canagliflozin, a sodium glucose co‐transporter 2 inhibitor, and assessment of dose proportionality in healthy participants. Clinical Pharmacology in Drug Development. 4(4). 279–286. 11 indexed citations
9.
Manitpisitkul, Prasarn, Christopher R. Curtin, Kevin Shalayda, et al.. (2014). Pharmacokinetics of topiramate in patients with renal impairment, end-stage renal disease undergoing hemodialysis, or hepatic impairment. Epilepsy Research. 108(5). 891–901. 20 indexed citations
10.
Manitpisitkul, Prasarn, Christopher R. Curtin, Kevin Shalayda, et al.. (2014). Pharmacokinetic interactions between topiramate and pioglitazone and metformin. Epilepsy Research. 108(9). 1519–1532. 19 indexed citations
11.
Devineni, Damayanthi, Prasarn Manitpisitkul, Nicole Vaccaro, et al.. (2014). Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on the pharmacokinetics of oral contraceptives, warfarin, and digoxin in healthy participants. International Journal of Clinical Pharmacology and Therapeutics. 53(1). 41–53. 16 indexed citations
12.
Manitpisitkul, Prasarn, Christopher R. Curtin, Kevin Shalayda, et al.. (2013). An Open-Label Drug–Drug Interaction Study of the Steady-State Pharmacokinetics of Topiramate and Glyburide in Patients with Type 2 Diabetes Mellitus. Clinical Drug Investigation. 33(12). 929–938. 2 indexed citations
13.
Sarich, Troy C., Margery A. Connelly, Atalanta Ghosh, et al.. (2012). A Phase 0 study of the inhibition of cholesteryl ester transfer protein activity by JNJ-28545595 in plasma from normolipidemic and dyslipidemic humans. International Journal of Clinical Pharmacology and Therapeutics. 50(8). 584–594. 3 indexed citations
14.
15.
Puri, Vinay, Seth Ness, Steven Wang, et al.. (2011). Long-Term Open-Label Study of Adjunctive Topiramate in Infants With Refractory Partial-Onset Seizures. Journal of Child Neurology. 26(10). 1271–1283. 15 indexed citations
16.
Schmidt, Stephan, Sreedharan Sabarinath, April Barbour, et al.. (2009). Pharmacokinetic-Pharmacodynamic Modeling of the In Vitro Activities of Oxazolidinone Antimicrobial Agents against Methicillin-ResistantStaphylococcus aureus. Antimicrobial Agents and Chemotherapy. 53(12). 5039–5045. 16 indexed citations
17.
Yang, Zheng, Prasarn Manitpisitkul, & Ronald J. Sawchuk. (2006). In situ studies of regional absorption of lobucavir and ganciclovir from rabbit intestine and predictions of dose‐limited absorption and associated variability in humans. Journal of Pharmaceutical Sciences. 95(10). 2276–2292. 6 indexed citations
18.
Prenner, Bruce M., Kenneth Kim, Samir K. Gupta, et al.. (2006). Adult and paediatric poor metabolisers of desloratadine: an assessment of pharmacokinetics and safety. Expert Opinion on Drug Safety. 5(2). 211–223. 17 indexed citations
19.
Manitpisitkul, Prasarn & Ronald E. White. (2004). Whatever happened to cassette-dosing pharmacokinetics?. Drug Discovery Today. 9(15). 652–658. 40 indexed citations
20.
Manitpisitkul, Prasarn & Win L. Chiou. (1993). Intravenous verapamil kinetics in rats: Marked arteriovenous concentration difference and comparison with humans. Biopharmaceutics & Drug Disposition. 14(7). 555–566. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martijn L. Manson Breakdown of academic impact, for papers by Yoshihiko Hirotani Breakdown of academic impact, for papers by Johan Wemer Breakdown of academic impact, for papers by Masataka Tajima Breakdown of academic impact, for papers by Megha Nagle Breakdown of academic impact, for papers by V. A. John Breakdown of academic impact, for papers by Adrian Pereira Breakdown of academic impact, for papers by Julie A. Johnson Breakdown of academic impact, for papers by Nihayet Bayraktar Breakdown of academic impact, for papers by Takeshi Akiyoshi
Rankless by CCL
2026